Botulinum toxin in the treatment of chronic migraine: a systematic revision
DOI:
https://doi.org/10.22491/2357-9730.125718Keywords:
Enxaqueca, Toxina Botulínica, Clostridium botulinumAbstract
Chronic migraine is caused by chemical changes in the brain, unilateral, pulsating pain of varying intensity. The administration of botulinum toxin, a neurotoxin produced by Clostridium botulinum, is an alternative treatment. There are different preparations of botulinum toxin, capable of inhibiting the release of acetylcholine, promoting muscle relaxation. The aim of the study was to analyze the therapeutic efficacy of botulinum toxin in the treatment of chronic migraine. A systematic review was carried out using the Main Items to Report Systematic Reviews and Meta-Analyses method as a supporting tool, using as descriptors: chronic migraine, botulinum toxin and treatment. Twenty-one articles were analyzed, of which 6 were meta-analyses and 15 were clinical trials, 9 clinical trials were compared to placebo and 6 to other therapies. The trials used a range of doses from 75 to 260 IU, and included patients with episodic and chronic migraine, in which the toxin was most effective. The toxin also had a good safety profile, with few adverse effects reported, which were generally mild or moderate. The study concluded that controlled clinical trials indicate that botulinum toxin type A was effective in treating chronic migraine. In comparison with the other drugs, it showed similar efficacy and a superior tolerability profile.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Andriele do Prado Mello, Laura Vicedo Jacociunas
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
